1-4 of 4
Ann F. Mohrbacher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma

Clinical Trials & Observations
Jeffrey A. Zonder, Ann F. Mohrbacher, Seema Singhal, Frits van Rhee, William I. Bensinger, Han Ding, John Fry, Daniel E. H. Afar, Anil K. Singhal
Journal: Blood
Blood (2012) 120 (3): 552–559.
https://doi.org/10.1182/blood-2011-06-360552
Published: 2012
Journal Articles

Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Two Doses of Bortezomib (Btz) in Patients with Relapsed Multiple Myeloma (MM).

A. Keith Stewart, MB, ChB, Dan Sullivan, MD, Sagar Lonial, MD, Ann F. Mohrbacher, MD, Gurkamal Chatta, MD, Chaim Shustik, MD, Howard Burris, III, Michael Karol, PhD, Peter Zannikos, PhD, Donna E. Reece, MD
Journal: Blood
Blood (2006) 108 (11): 3533.
https://doi.org/10.1182/blood.V108.11.3533.3533
Published: 2006
Journal Articles

Results of a Pilot Trial of Fludarabine, Mitoxantrone and Rituxan in Mantle Cell Lymphoma.

Alexandra M. Levine, MD, Anil Tulpule, MD, Lynne Smith, PhD, Byron M. Espina, AB, Ann F. Mohrbacher, MD, Donald I. Feinstein, MD
Journal: Blood
Blood (2005) 106 (11): 945.
https://doi.org/10.1182/blood.V106.11.945.945
Published: 2005
Journal Articles

Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications

Brief Report
TuDung T. Nguyen, Ann F. Mohrbacher, Yvonne C. Tsai, John Groffen, Nora Heisterkamp, Peter W. Nichols, Mimi C. Yu, Michael Lübbert, Peter A. Jones
Journal: Blood
Blood (2000) 95 (9): 2990–2992.
https://doi.org/10.1182/blood.V95.9.2990.009k08_2990_2992
Published: 2000